跳至主要内容
临床试验/ISRCTN10139334
ISRCTN10139334进行中(未招募)未知

A clinical pharmacology study to investigate the utility of therapeutic drug monitoring in challenging childhood cancer patient populations

ewcastle upon Tyne Hospitals NHS Foundation Trust0 个研究点目标入组 150 人开始时间: 2019年5月10日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Age <18 years.
  • 2. Confirmed diagnosis of cancer.
  • 3. Patient receiving a ‘non-standard’ strategy of chemotherapy delivery (see below for examples of patient groups that fall into this category).*
  • 4. Appropriate venous access.
  • 5. Request from the treating clinician for therapeutic drug monitoring approach to treatment.
  • 6. Willingness to participate and written informed parental/patient consent (signed and dated).
  • * Patients receiving non-standard chemotherapy dosing regimens will include the following groups: pre-term infants and neonates, anephric patients, patients receiving high dose myeloablative chemotherapy, patients undergoing chemoembolisation procedures, obese patients (BMI at or above the 95th percentile for children of the same age and sex).

排除标准

  • Failure to meet the inclusion criteria.

研究者

发起方
ewcastle upon Tyne Hospitals NHS Foundation Trust

相似试验

Therapeutic drug monitoring in children with cancer | 临床试验